R17Dagger codeAsterisk code

Unspecified jaundice

Cited in 1 document

GuidelinesCircular August 2024: Emicizumab for prophylaxis in the management of patients with Haemophilia A with Factor VIII inhibitorsDate: March 2023 (updated November 2023, March 2024, and August 2024) NOTE: Efficacy and safety evidence was presented to the National Essential Medicines List Committee (NEMLC) in March 2023. It was proposed by the Tertiary and Quaternary Hospital Level Expert Review Committee (and agreed to by the NEMLC) that a cost-effectiveness analysis be conducted. Scoping document for cost-effectiveness an